medigraphic.com
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

2007, Number 3

<< Back Next >>

Rev Invest Clin 2007; 59 (3)

Abdomen agudo no quirúrgico como presentación clínica de Fiebre Mediterránea Familiar

Halabe-Cherem J, Rábago-Arredondo J

Language: Spanish
References: 22
Page: 212-218
PDF size: 79.23 Kb.


Text Extraction

No abstract


REFERENCES

  1. Cherem JH, Hummel HN, Padilla GF. Familial Mediterranean fever in Mexico City: 10-year follow-up. Archives of Internal Medicine 1994; 154(12): 1411, 4.

  2. Halabe J, Islas S, Mercado M. Fiebre Mediterránea familiar en la ciudad de México. Rev Invest Clin 1986; 38: 389-93.

  3. Ozdemir A. Familial mediterranean fever among the turkish people. Am J Gastroenterol 1969(51): 311-6.

  4. Livneh A, Langevitz P. Diagnostic and treatment concerns in familial Mediterranean fever. Bailliere’s Best Practice & Research 2000; 14(3): 477-98.

  5. Avila R, Halabe J, Lifshitz A. Patogenia de la fiebre mediterránea familiar. Rev Med IMSS 1987; (25): 321-9.

  6. The International FMF Consortium. Cell 1997; (17): 25-31.

  7. The French FMF Consortium. Nat Genet 1997; (17): 25-31.

  8. Halabe J, Nellen H, Flores G. Familial mediterranean fever and primary antiphospholipid, a rare association. Angiology 1995; (46): 859-61.

  9. Disdier P. Familial mediterranean fever crisis and lupus anticoagulant. Lancet 1996; (348): 1321-2.

  10. Cook G. Familial mediterranean fever: underlying defect clearer, but diagnosis problems persist. Lancet 1996; (1996): 1779-80.

  11. Balow J. A high resolution genetic map of the familial mediterranean fever. Genomics 1997; (44): 280-91.

  12. Rogers D. Familial mediterranean fever. Am J Med Genet 1989; (34): 168-72.

  13. Babior B, Matzner Y. The familial mediterranean fever genecloned at last. N Engl J Med 1997; (337): 1548-9.

  14. Schaner PE, Gumucio DL. Familial Mediterranean fever in the post-genomic era: how an ancient disease is providing new insights into inflammatory pathways. Current Drug Targets 2005; 4(1): 67-76.

  15. Masumoto J, Dowds TA, Schaner P, et al. ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis. Biochemical and Biophysical Research Communications 2003; 303(1): 69-73.

  16. Koklu S, Ozturk MA, Balci M, Yuksel O, Ertenli I, Kiraz S. Interferon- gamma levels in familial Mediterranean fever. Joint Bone Spine 2005; 72(1): 38-40.

  17. Gershoni-Baruch R, Brik R, Shinawi M, Livneh A. The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet 2002; 10(2): 145-9.

  18. Halabe J, Islas S, Lifshitz A. Persistent fever as the only symptom of familial mediterranean fever. Archives of Internal Medicine 1990; (150): 1347.

  19. Pras E. Familial mediterranean fever. N Engl J Med 1992; 326: 1509-13.

  20. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. A survey of 470 cases and review of the literature. Am J Med 1967; 43(2): 227-53.

  21. Livneh A, Langevitz P, Zemer D, et al. The changing face of familial Mediterranean fever. Seminars in Arthritis and Rheumatism 1996; 26(3): 612-27.

  22. Zemer D, Revach M, Pras M, et al. A controlled trial of colchicine in preventing attacks of familial mediterranean fever. N Engl J Med 1974; 291(18): 932-4.




2020     |     www.medigraphic.com